e001248.full.pdf (5.39 MB)
Download file

Recommendations for Management of Diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD Consensus

Download (5.39 MB)
journal contribution
posted on 06.05.2020, 12:05 by M Ibrahim, M Davies, E Ahmad, FA Annabi, R Eckel, A Ba-Essa, N El Sayed, A Fischl, P Houeiss, H Iraqi, I Khochtali, K Khunti, S Masood, S Mimouni-Zerguini, S Shra, J Tuomilehto, G Umpierrez

Fasting the Holy month of Ramadan constitutes one of the five pillars of the Muslim faith.

Although there is some evidence that intermittent fasting during Ramadan may be of benefit in losing weight and cardiometabolic risk factors, there is no strong evidence these benefits apply to people with diabetes. The ADA/EASD consensus recommendations emphasize the importance of patient factors and co-morbidities when choosing diabetes medications including the presence of co-morbidities, atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney disease (CKD), hypoglycaemia risk, weight issues and costs.

Structured education and pre-Ramadan counselling are key components to successful management of patients with diabetes. These should cover important aspects like glycaemic targets, self-monitoring of blood glucose (SMBG), diet, physical activity including Taraweeh prayers, medication and dose adjustment, side effects and when to break the fast. The Decision Cycle in figure 1 adapted for the specific situation of Ramadan provides an aid for such an assessment.

Children with type 1 diabetes should strongly be advised not to fast due to the high risk of acute complications such as hypoglycaemia and probably diabetic ketoacidosis (DKA), although there is very little evidence that DKA is increased in Ramadan. [1]

Pregnant women with diabetes or gestational diabetes should be advised to avoid fasting because of possible negative maternal and fetal outcomes.

Hypoglycaemia is a common concern during Ramadan fasting. To prevent hypoglycaemic and hyperglycaemic events, we recommend the adoption of diabetes self-management education and support (DSMES) principles.

The use of the emerging technology and continuous glucose monitoring (CGM) during Ramadan could help to recognize hypoglycaemic and hyperglycaemic complications related to omission and/or medication adjustment during fasting; however, the cost represents a significant barrier.

Funding

This research was supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), the NIHR Leicester Clinical Research Facility (CRF) and the NIHR Applied Research Collaboration East Midlands (ARC–EM).

History

Citation

Ibrahim M, Davies MJ, Ahmad E, et alRecommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensusBMJ Open Diabetes Research and Care 2020;8:e001248. doi: 10.1136/bmjdrc-2020-001248

Published in

BMJ Open Diabetes Research and Care

Volume

8

Pagination

e001248

Publisher

BMJ Publishing Group

issn

2052-4897

Acceptance date

06/04/2020

Copyright date

2020

Available date

04/05/2020

Publisher version

https://drc.bmj.com/content/8/1/e001248

Language

en

Usage metrics

Categories

Exports